Xu, S.; Hultström, M.; Larsson, A.; Lipcsey, M.; Lindskog, C.; Bülow, S.; Frithiof, R.; Venge, P.
The Human Phospholipase B-II Precursor (HPLBII-P) in Urine as a Novel Biomarker of Glomerular Activity in COVID-19 and Diabetes Mellitus. J. Clin. Med. 2024, 13, 2540.
https://doi.org/10.3390/jcm13092540
AMA Style
Xu S, Hultström M, Larsson A, Lipcsey M, Lindskog C, Bülow S, Frithiof R, Venge P.
The Human Phospholipase B-II Precursor (HPLBII-P) in Urine as a Novel Biomarker of Glomerular Activity in COVID-19 and Diabetes Mellitus. Journal of Clinical Medicine. 2024; 13(9):2540.
https://doi.org/10.3390/jcm13092540
Chicago/Turabian Style
Xu, Shengyuan, Michael Hultström, Anders Larsson, Miklos Lipcsey, Cecilia Lindskog, Sara Bülow, Robert Frithiof, and Per Venge.
2024. "The Human Phospholipase B-II Precursor (HPLBII-P) in Urine as a Novel Biomarker of Glomerular Activity in COVID-19 and Diabetes Mellitus" Journal of Clinical Medicine 13, no. 9: 2540.
https://doi.org/10.3390/jcm13092540
APA Style
Xu, S., Hultström, M., Larsson, A., Lipcsey, M., Lindskog, C., Bülow, S., Frithiof, R., & Venge, P.
(2024). The Human Phospholipase B-II Precursor (HPLBII-P) in Urine as a Novel Biomarker of Glomerular Activity in COVID-19 and Diabetes Mellitus. Journal of Clinical Medicine, 13(9), 2540.
https://doi.org/10.3390/jcm13092540